Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block on Postoperative Pain After Septoplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUmraniye Education and Research Hospital

About this trial

The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:

Will the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.

Participants will:

Read the information Participants have been given about the sphenopalatine ganglion block.

In case of any side effects, please contact participant's doctor.

Eligibility criteria

Qualifiers

Participants who will undergo septoplasty

18 to 50 years old

ASA score 1 or 2

Disqualifiers

Under 18 or over 50 years of age

ASA score III and above patient group

The patient is allergic to any of the drugs used

The patient has a contraindication to any of the drugs used

Trial design

Treatments tested in this trial

  • Sphenopalatine Ganglion Block

Treatment groups

50 Participants
are divided into 2 treatment groups

Locations

This trial has no locations